FBT

First Trust Nyse Arca Biotec

+$932.9M

Net Activity

Institutions Holding

304

Popularity Rank

#1950

Avg Weight

0.12%

Total Value

$1.6B

Ownership Trend

304 institutions currently hold FBT, with 160 net buyers and 97 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

97

Net Buying Institutions

160

Key Holders

View all 304 holding institutions

Quarterly Activity

Recent Activity

+$1.6B

Total Buy Value

$167.9M

Total Sell Value

New buy54
Trim72
Add106
Sold out25

160

Net Buyers

97

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding FIRST TRUST NYSE ARCA BIOTEC (FBT)?
Major stakeholders currently include First Trust Advisors LP ($705.9M), Morgan Stanley ($107.3M), Wells Fargo & Company/mn ($85.6M). Based on the latest 13F filings, there are a total of 304 tracked investment funds and institutions maintaining positions in FBT.
What is the overall institutional sentiment toward FBT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $932.9M, driven by 160 managers accumulating shares while 97 reduced their exposure.
Which institutions have been selling or reducing their FBT positions?
In the latest period, 72 funds trimmed their holdings, and 25 managers completely exited their positions. The aggregate reported sell value was $167.9M.
Are there any notable investors adding FBT to their portfolios?
Yes, buying activity remains notable. 54 institutions opened new positions in {ticker}, and 106 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.6B.

Related Stocks